Medical Centre "Asklepiy"

Dupnitsa, Kyustendil 2600

1 studies enrolling now · 3 studies all time

What they study most

COVID-19 SARS-CoV-2 Infection, Diabetes Mellitus, Obesity, Vitiligo

Studies at this site

• A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease — Recruiting now
• A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo — Running, not enrolling
• Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity — Stopped early